Barth syndrome

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 163, Issue 3, 2013, Pages 198-205

  Jefferies, John L ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Barth syndrome; Cardiomyopathy; Genetics; Heart failure

Indexed keywords

3 METHYLGLUTACONIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOLIPIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; ENZYME; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH HORMONE; POTASSIUM SPARING DIURETIC AGENT; TAFAZZIN; UNCLASSIFIED DRUG; VASODILATOR AGENT; TAZ PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; BACTERIAL INFECTION; BARTH SYNDROME; BIRTH; BONE MARROW BIOPSY; CARDIOMYOPATHY; CHROMOSOME; CHROMOSOME XQ28; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DISEASE REGISTRY; GENE; GENE MUTATION; GENETICS; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MORBIDITY; MORTALITY; MYOPATHY; NEUTROPENIA; NEUTROPHIL; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SEPSIS; SURVIVAL; SURVIVAL RATE; VENTRICULAR NONCOMPACTION; CARDIOMYOPATHIES; GENETIC PREDISPOSITION; MUTATION;

BACTERIA (MICROORGANISMS);

BARTH SYNDROME; CARDIOMYOPATHIES; GENETIC PREDISPOSITION TO DISEASE; HEART FAILURE; HUMANS; MUTATION; PHENOTYPE; TRANSCRIPTION FACTORS;

EID: 84880702851     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.31372     Document Type: Article

References (52)

1. Acehan D, Xu Y, Stokes DL, Schlame M. 2007. Comparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomography. Lab Invest 87:40-48.
2. Acehan DF, Vaz F, Houtkooper RH, James J, Moore V, Tokunaga C, Kulik W, Wansapura J, Toth MJ, Strauss A, Khuchua Z. 2011. Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome. J Biol Chem 286:899-908.
3. Ades LC, Gedeon AK, Wilson MJ, Latham M, Partington MW, Mulley JC, Nelson J, Lui K, Sillence DO. 1993. Barth syndrome: Clinical features and confirmation of gene localisation to distal Xq28. Am J Med Genet 45:327-334.
4. Barth PG, Scholte HR, Berden JA, Van der Klei-Van Moorsel JM, Luyt-Houwen IE, Van't Veer-Korthof ET, Van der Harten JJ, Sobotka-Plojhar MA. 1983. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 62:327-355.
5. Barth PG, Valianpour F, Bowen VM, Lam J, Duran M, Vaz FM, Wanders RJ. 2004. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): An update. Am J Med Genet Part A 126A:349-354.
6. Bayeva M, Gheorghiade M, Ardehali H. 2013. Mitochondria as a therapeutic target in heart failure. J Am Coll Cardiol 61:599-610.
7. Bione S, D'Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, Toniolo D. 1996. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet 12:385-389.
8. Bleyl SB, Mumford BR, Thompson V, Carey JC, Pysher TJ, Chin TK, Ward K. 1997. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet 61:868-872.
9. Bolhuis PA, Hensels GW, Hulsebos TJ, Baas F, Barth PG. 1991. Mapping of the locus for X-linked cardioskeletal myopathy with neutropenia and abnormal mitochondria (Barth syndrome) to Xq28. Am J Hum Genet 48:481-485.
10. Brescia ST, Rossano JW, Pignatelli R, Jefferies JL, Price JF, Decker JA, Denfield SW, Dreyer WJ, Smith O, Towbin JA, Kim JJ. 2013. Mortality and sudden death in pediatric left ventricular noncompaction in a tertiary referral center. Circulation 127:2202-2208.
11. Cantlay AM, Shokrollahi K, Allen JT, Lunt PW, Newbury-Ecob RA, Steward CG. 1999. Genetic analysis of the G4.5 gene in families with suspected Barth syndrome. J Pediatr 135:311-315.
12. Chang B, Momoi N, Shan L, Mitomo M, Aoyagi Y, Endo K, Takeda I, Chen R, Xing Y, Yu X, Watanabe S, Yoshida T, Kanegane H, Tsubata S, Bowles NE, Ichida F, Miyawaki T, Noncompaction Study Collaborators. 2010. Gonadal mosaicism of a TAZ (G4.5) mutation in a Japanese family with Barth syndrome and left ventricular noncompaction. Mol Genet Metab 100:198-203.
13. Christodoulou J, McInnes RR, Jay V, Wilson G, Becker LE, Lehotay DC, Platt BA, Bridge PJ, Robinson BH, Clarke JT. 1994. Barth syndrome: Clinical observations and genetic linkage studies. Am J Med Genet 50:255-264.
14. Coman D, Yaplito-Lee J, Boneh A. 2008. New indications and controversies in arginine therapy. Clin Nutr 27:489-496.
15. Cosson L, Toutain A, Simard G, Kulik W, Matyas G, Guichet A, Blasco H, Maakaroun-Vermesse Z, Vaillant MC, Le Caignec C, Chantepie A, Labarthe F. 2012. Barth syndrome in a female patient. Mol Genet Metab 106:115-120.
16. D'Adamo P, Fassone L, Gedeon A, Janssen EA, Bione S, Bolhuis PA, Barth PG, Wilson M, Haan E, Orstavik KH, Patton MA, Green AJ, Zammarchi E, Donati MA, Toniolo D. 1997. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet 61:862-867.
17. Dedieu N, Giardini A, Steward CG, Fenton M, Karimova A, Hsia TY, Burch M. 2013. Successful mechanical circulatory support for 251 days in a child with intermittent severe neutropenia due to Barth syndrome. Pediatr Transplant 17:E46-E49.
18. Finsterer J, Frank M. 2013. Haematological features in Barth syndrome. Curr Opin Hematol 20:36-40.
19. Fraser CD Jr, Jaquiss RD, Rosenthal DN, Humpl T, Canter CE, Blackstone EH, Naftel DC, Ichord RN, Bomgaars L, Tweddell JS, Massicotte MP, Turrentine MW, Cohen GQ, Devaney EJ, Pearce FB, Carberry KE, Kroslowitz R, Almond CS, Berlin Heart Study. 2012. Prospective trial of a pediatric ventricular assist device. N Engl J Med 367:532-541.
20. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons. 2011. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124:2761-2796.
21. Gonzalez IL. 2005. Barth syndrome: TAZ gene mutations, mRNAs, and evolution. Am J Med Genet Part A 134A:409-414.
22. Gonzalvez F, Gottlieb E. 2007. Cardiolipin: Setting the beat of apoptosis. Apoptosis 12:877-885.
23. Hanke SP, Gardner AB, Lombardi JP, Manning PB, Nelson DP, Towbin JA, Jefferies JL, Lorts A. 2012. Left ventricular noncompaction cardiomyopathy in barth syndrome: An example of an undulating cardiac phenotype necessitating mechanical circulatory support as a bridge to transplantation. Pediatr Cardiol 33:1430-1434.
24. Houtkooper RH, Rodenburg RJ, Thiels C, van Lenthe H, Stet F, Poll-The BT, Stone JE, Steward CG, Wanders RJ, Smeitink J, Kulik W, Vaz FM. 2009. Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome. Anal Biochem 387:230-237.
25. Jefferies JL, Morales DL. 2012. Mechanical circulatory support in children: Bridge to transplant versus recovery. Curr Heart Fail Rep 9:236-243.
26. Jefferies JL, Towbin JA. 2010. Dilated cardiomyopathy. Lancet 375:752-762.
27. Jessup M, Brozena SC. 2007. Guidelines for the management of heart failure: Differences in guideline perspectives. Cardiol Clin 25:497-506; v.
28. Johnston J, Kelley RI, Feigenbaum A, Cox GF, Iyer GS, Funanage VL, Proujansky R. 1997. Mutation characterization and genotype-phenotype correlation in Barth syndrome. Am J Hum Genet 61:1053-1058.
29. Kiebish MA, Han X, Cheng H, Chuang JH, Seyfried TN. 2008. Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: Lipidomic evidence supporting the Warburg theory of cancer. J Lipid Res 49:2545-2556.
30. Klaassen S, Probst S, Oechslin E, Gerull B, Krings G, Schuler P, Greutmann M, Hurlimann D, Yegitbasi M, Pons L, Gramlich M, Drenckhahn JD, Heuser A, Berger F, Jenni R, Thierfelder L. 2008. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation 117:2893-2901.
31. Klingenberg M. 2009. Cardiolipin and mitochondrial carriers. Biochim Biophys Acta 1788:2048-2058.
32. Koshkin V, Greenberg ML. 2002. Cardiolipin prevents rate-dependent uncoupling and provides osmotic stability in yeast mitochondria. Biochem J 364:317-322.
33. Kuijpers TW, Maianski NA, Tool AT, Becker K, Plecko B, Valianpour F, Wanders RJ, Pereira R, Van Hove J, Verhoeven AJ, Roos D, Baas F, Barth PG. 2004. Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis. Blood 103:3915-3923.
34. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J, American Heart Association Statistics, Stroke Statistics. 2010. Executive summary: Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 121:948-954.
35. Man E, Lafferty KA, Funke BH, Lun KS, Chan SY, Chau AK, Chung BH. 2013. NGS identifies TAZ mutation in a family with X-linked dilated cardiomyopathy. BMJ Case Rep 2013. doi:pii: bcr2012007529. 10.1136/bcr-2012-007529
36. Mangat J, Lunnon-Wood T, Rees P, Elliott M, Burch M. 2007. Successful cardiac transplantation in Barth syndrome-Single-centre experience of four patients. Pediatr Transplant 11:327-331.
37. Neustein HB, Lurie PR, Dahms B, Takahashi M. 1979. An X-linked recessive cardiomyopathy with abnormal mitochondria. Pediatrics 64:24-29.
38. Neuwald AF. 1997. Barth syndrome may be due to an acyltransferase deficiency. Curr Biol 7:R465-R466.
39. Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC, Davis AM, Kahler SG, Chow CW, Wilkinson JL, Weintraub RG. 2003. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 348:1639-1646.
40. Pignatelli RH, McMahon CJ, Dreyer WJ, Denfield SW, Price J, Belmont JW, Craigen WJ, Wu J, El Said H, Bezold LI, Clunie S, Fernbach S, Bowles NE, Towbin JA. 2003. Clinical characterization of left ventricular noncompaction in children: A relatively common form of cardiomyopathy. Circulation 108:2672-2678.
41. Rigaud C, Lebre AS, Touraine R, Beaupain B, Ottolenghi C, Chabli A, Ansquer H, Ozsahin H, Di Filippo S, De Lonlay P, Borm B, Rivier F, Vaillant MC, Mathieu-Dramard M, Goldenberg A, Viot G, Charron P, Rio M, Bonnet D, Donadieu J. 2013. Natural history of Barth syndrome: A national cohort study of 22 patients. Orphanet J Rare Dis 8:70.
42. Roberts AE, Nixon C, Steward CG, Gauvreau K, Maisenbacher M, Fletcher M, Geva J, Byrne BJ, Spencer CT. 2012. The Barth Syndrome Registry: Distinguishing disease characteristics and growth data from a longitudinal study. Am J Med Genet Part A 158A:2726-2732.
43. Ronvelia D, Greenwood J, Platt J, Hakim S, Zaragoza MV. 2012. Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle. Mol Genet Metab 107:428-432.
44. Schlame M, Towbin JA, Heerdt PM, Jehle R, DiMauro S, Blanck TJ. 2002. Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann Neurol 51:634-637.
45. Spencer CT, Byrne BJ, Gewitz MH, Wechsler SB, Kao AC, Gerstenfeld EP, Merliss AD, Carboni MP, Bryant RM. 2005. Ventricular arrhythmia in the X-linked cardiomyopathy Barth syndrome. Pediatr Cardiol 26:632-637.
46. Spencer CT, Bryant RM, Day J, Gonzalez IL, Colan SD, Thompson WR, Berthy J, Redfearn SP, Byrne BJ. 2006. Cardiac and clinical phenotype in Barth syndrome. Pediatrics 118:e337-e346.
47. Towbin JA. 2010. Left ventricular noncompaction: A new form of heart failure. Heart Fail Clin 6:453-469, viii.
48. Towbin JA, Bowles NE. 2002. The failing heart. Nature 415:227-233.
49. Valianpour F, Mitsakos V, Schlemmer D, Towbin JA, Taylor JM, Ekert PG, Thorburn DR, Munnich A, Wanders RJ, Barth PG, Vaz FM. 2005. Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis. J Lipid Res 46:1182-1195.
50. van Raam BJ, Kuijpers TW. 2009. Mitochondrial defects lie at the basis of neutropenia in Barth syndrome. Curr Opin Hematol 16:14-19.
51. Vreken P, Valianpour F, Nijtmans LG, Grivell LA, Plecko B, Wanders RJ, Barth PG. 2000. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Commun 279:378-382.
52. Yen TY, Hwu WL, Chien YH, Wu MH, Lin MT, Tsao LY, Hsieh WS, Lee NC. 2008. Acute metabolic decompensation and sudden death in Barth syndrome: Report of a family and a literature review. Eur J Pediatr 167:941-944.